Treatments, Skin smoothing, Wrinkle relaxing
At CLARA Dermatology, we are always evaluating the latest innovations in aesthetic dermatology to provide patients with safe, effective, and natural-looking results. One of the newest and most exciting additions to wrinkle treatment options in the United States is Letybo®, the latest FDA-approved neuromodulator to enter the market.
Here’s what patients should know about Letybo — and why its international track record makes it an exciting option for wrinkle treatment.
Letybo is a botulinum toxin type A injectable treatment used to temporarily relax the facial muscles responsible for dynamic wrinkles, including:
Like other neuromodulators, it works by blocking nerve signals to targeted muscles, allowing overlying skin to smooth and soften while maintaining natural facial expression when properly administered.
Letybo recently received approval from the U.S. Food and Drug Administration, making it available for patients in the United States after years of successful international use.
One of the most exciting aspects of Letybo is its development and widespread use in South Korea, a global leader in cosmetic dermatology and aesthetic innovation.
South Korea is known worldwide for its advanced approach to skincare and aesthetic medicine, driven by:
Because injectable treatments are so common in Korea, products must demonstrate excellent performance and safety before gaining widespread acceptance. Letybo has already built a strong track record there, giving U.S. dermatologists confidence as it enters the American market.
Patients increasingly want refreshed, relaxed appearances rather than frozen expressions, which aligns with CLARA’s approach. Properly injected Letybo allows for softening of wrinkles while maintaining normal facial movement.
Predictable onset and duration are essential for treatment planning, and clinical experience shows Letybo performs similarly to established neuromodulators.
Years of international use provide reassuring data regarding safety and effectiveness.
Not all patients respond the same to every neuromodulator. Having additional FDA-approved options allows dermatologists to tailor treatment plans for optimal individual results.
Patients considering Letybo treatments can expect:
Treatment sessions are brief, and most patients return immediately to normal daily activities.
The introduction of new neuromodulators like Letybo expands treatment possibilities. Dermatologists can better customize wrinkle treatments for:
The ability to personalize treatment leads to better long-term satisfaction and results.
While the product matters, results ultimately depend on expert injection technique and individualized treatment planning. Understanding facial anatomy, muscle balance, and patient goals is key to achieving natural outcomes.
At CLARA Dermatology, our dermatology team carefully evaluates each patient to determine the most appropriate neuromodulator and injection strategy for optimal results.
The arrival of Letybo in the United States represents continued innovation in aesthetic dermatology. With its strong track record in South Korea and FDA approval in the U.S., it provides patients with another safe, effective option for wrinkle reduction and prevention.
If you’re interested in learning whether Letybo or another neuromodulator is right for you, schedule a consultation with one of our board-certified dermatologists or, if you’re ready for treatment, book one now – see you soon!
Get your customized skin care plan.
We respect your privacy and your inbox. We’ll never sell your address. Unsubscribe anytime.
© 2022 Clara Dermatology. All rights reserved.
